Lolli F, Pallotti F, Rossi A, et al. Androgenetic alopecia: a review. Endocrine. 2017;57(1):9–17. https://doi.org/10.1007/s12020-017-1280-y.

Article  CAS  PubMed  Google Scholar 

Villasante Fricke AC, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol. 2015;8:397–403. https://doi.org/10.2147/CCID.S53985.

Article  PubMed  PubMed Central  Google Scholar 

US FDA. Drug Approval Package: Rogaine NDA# 020834. https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020834_rogaine_toc.cfm.

US FDA. Loniten. Published online 2015. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018154s026lbl.pdf.

Yesudian P. Serendipity in trichology. Int J Trichol. 2011;3(1):1–2. https://doi.org/10.4103/0974-7753.82116.

Article  Google Scholar 

Desir N, Desai AD, Lipner SR. Increased interest in oral minoxidil for hair loss treatment following publication of August 2022 New York Times article: a Google trends analysis. Skin Appendage Disord. 2024;10(1):46–9. https://doi.org/10.1159/000534526.

Article  PubMed  Google Scholar 

Kolata G. An old medicine grows new hair for pennies a day, doctors say. The New York Times. 2022. https://www.nytimes.com/2022/08/18/health/minoxidil-hair-loss-pills.html. Accessed 4 Apr 2025.

Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737–46. https://doi.org/10.1016/j.jaad.2020.06.1009.

Article  CAS  PubMed  Google Scholar 

Kowe PA, Madke B, Bansod SH. Oral minoxidil in trichology: a review. Indian J Drugs Dermatol. 2022;8(1):1. https://doi.org/10.4103/ijdd.ijdd_35_21.

Article  Google Scholar 

Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension | Circulation. https://doi.org/10.1161/01.CIR.45.3.571. Accessed 4 Apr 2025.

Kolata G. Hair-Growth Drug Approved, The First Cleared in the U.S. The New York Times. 1988. https://www.nytimes.com/1988/08/18/us/hair-growth-drug-approved-the-first-cleared-in-the-us.html. Accessed 4 Apr 2025.

Buhl AE, Waldon DJ, Baker CA, Johnson GA. Minoxidil sulfate is the active metabolite that stimulates hair follicles. J Invest Dermatol. 1990;95(5):553–7. https://doi.org/10.1111/1523-1747.ep12504905.

Article  CAS  PubMed  Google Scholar 

Dooley TP. Molecular biology of the human cytosolic sulfotransferase gene superfamily implicated in the bioactivation of minoxidil and cholesterol in skin. Exp Dermatol. 1999;8(4):328–9. https://doi.org/10.1159/000026112.

Article  CAS  PubMed  Google Scholar 

Olsen EA, Sinclair R, Hordinsky M, et al. Summation and recommendations for the safe and effective use of topical and oral minoxidil. J Am Acad Dermatol. 2025;93:S0190–9622(25)00605-X. https://doi.org/10.1016/j.jaad.2025.04.016.

Article  PubMed  Google Scholar 

Meisheri KD, Cipkus LA, Taylor CJ. Mechanism of action of minoxidil sulfate-induced vasodilation: a role for increased K+ permeability. J Pharmacol Exp Ther. 1988;245(3):751–60.

Article  CAS  PubMed  Google Scholar 

Buhl AE, Conrad SJ, Waldon DJ, Brunden MN. Potassium channel conductance as a control mechanism in hair follicles. J Invest Dermatol. 1993;101(1 Suppl):148S-152S. https://doi.org/10.1111/1523-1747.ep12363290.

Article  CAS  PubMed  Google Scholar 

Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150(2):186–94. https://doi.org/10.1111/j.1365-2133.2004.05785.x.

Article  CAS  PubMed  Google Scholar 

Gupta AK, Talukder M, Shemer A, Piraccini BM, Tosti A. Low-dose oral minoxidil for alopecia: a comprehensive review. Skin Appendage Disord. 2023;9(6):423–37. https://doi.org/10.1159/000531890.

Article  PubMed  PubMed Central  Google Scholar 

Sato T, Li Y, Saito T, Nakaya H. Minoxidil opens mitochondrial KATP channels and confers cardioprotection. Br J Pharmacol. 2004;141(2):360–6. https://doi.org/10.1038/sj.bjp.0705613.

Article  CAS  PubMed  Google Scholar 

Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S. Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2012;6(2):130–6. https://doi.org/10.2174/187221312800166859.

Article  CAS  PubMed  Google Scholar 

Davies GC, Thornton MJ, Jenner TJ, et al. Novel and established potassium channel openers stimulate hair growth in vitro: implications for their modes of action in hair follicles. J Invest Dermatol. 2005;124(4):686–94. https://doi.org/10.1111/j.0022-202X.2005.23643.x.

Article  CAS  PubMed  Google Scholar 

McClenaghan C, Nichols CG. Kir6.1 and SUR2B in Cantú syndrome. Am J Physiol-Cell Physiol. 2022. https://doi.org/10.1152/ajpcell.00154.2022.

Article  PubMed  PubMed Central  Google Scholar 

Rishikaysh P, Dev K, Diaz D, Qureshi WMS, Filip S, Mokry J. Signaling involved in hair follicle morphogenesis and development. Int J Mol Sci. 2014;15(1):1647–70. https://doi.org/10.3390/ijms15011647.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kwack MH, Kang BM, Kim MK, Kim JC, Sung YK. Minoxidil activates β-catenin pathway in human dermal papilla cells: a possible explanation for its anagen prolongation effect. J Dermatol Sci. 2011;62(3):154–9. https://doi.org/10.1016/j.jdermsci.2011.01.013.

Article  CAS  PubMed  Google Scholar 

Liu J, Xiao Q, Xiao J, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Sig Transduct Target Ther. 2022;7(1):1–23. https://doi.org/10.1038/s41392-021-00762-6.

Article  CAS  Google Scholar 

Lachgar S, Charveron M, Gall Y, Bonafe JL. Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells. Br J Dermatol. 1998;138(3):407–11. https://doi.org/10.1046/j.1365-2133.1998.02115.x.

Article  CAS  PubMed  Google Scholar 

Michelet JF, Commo S, Billoni N, Mahé YF, Bernard BA. Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair growth-stimulating effect. J Invest Dermatol. 1997;108(2):205–9. https://doi.org/10.1111/1523-1747.ep12334249.

Article  CAS  PubMed  Google Scholar 

Pekmezci E, Turkoğlu M, Gökalp H, Kutlubay Z. Minoxidil downregulates Interleukin-1 alpha gene expression in HaCaT cells. Int J Trichology. 2018;10(3):108. https://doi.org/10.4103/ijt.ijt_18_17.

Article  PubMed  PubMed Central  Google Scholar 

Nirmal B, Somiah S, Sacchidanand SA, Biligi DS, Palo S. Evaluation of perifollicular inflammation of donor area during hair transplantation in androgenetic alopecia and its comparison with controls. Int J Trichology. 2013;5(2):73–6. https://doi.org/10.4103/0974-7753.122963.

Article  PubMed  PubMed Central  Google Scholar 

Plante J, Valdebran M, Forcucci J, Lucas O, Elston D. Perifollicular inflammation and follicular spongiosis in androgenetic alopecia. J Am Acad Dermatol. 2022;86(2):437–8. https://doi.org/10.1016/j.jaad.2021.09.040.

Article  PubMed  Google Scholar 

Ly N, McClure EM, Hordinsky MK, Farah RS, Park SY. Safety and efficacy of minoxidil treatment in scarring alopecia: a scoping review. J Drugs Dermatol. 2024;23(3):146–51. https://doi.org/10.36849/jdd.7743.

Article  PubMed  Google Scholar 

Sawaya ME, Price VH. Different levels of 5α-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol. 1997;109(3):296–300.

Article  CAS  PubMed  Google Scholar 

Schweikert HU, Wilson JD. Regulation of human hair growth by steroid hormones. I. Testosterone metabolism in isolated hairs. J Clin Endocrinol Metab. 1974;38(5):811–9. https://doi.org/10.1210/jcem-38-5-811.

Article  CAS  PubMed